Peer-influenced content. Sources you trust. No registration required. This is HCN.
Sleep-Wake Advisor
A supervised random forest classifier trained on 330 features derived from nocturnal polysomnography achieved areas under the ROC curve approaching or exceeding 0.8 for distinguishing narcolepsy type 2, idiopathic hypersomnia, and controls in a national French reference database.
Neurology June 23rd 2026
ReachMD
Approved? Not-approved? What is “tentative approval?” Clinical trial data on this novel “once nightly” sodium oxibate showed the drug to be acceptable for narcolepsy. But legal issues are holding up the FDA approval process.
Internal Medicine January 18th 2023
After completing this 3-chapter, 0.25-credit CME program, participants should be better able to assess the effectiveness and safety of current and novel therapies in improving outcomes for narcolepsy patients. They should also be able to define the methods by which patients and healthcare professionals can collaborate more effectively to define treatment goals and make decisions that will improve therapeutic outcomes.
Internal Medicine November 8th 2022